Showing results (381-390 of 557) with videos related to
Sort By:
Pageof 56
Oncotarget|September 15, 2016
Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancerYun-Peng Peng, Chun-Hua Xi, Yi Zhu, et al.Frontiers in Psychiatry|December 24, 2021
COVID-19 Vaccine-Related Psychological Stress Among General Public in ChinaYong-Bo Zheng, Jie Sun, Lin Liu, et al.Journal of Cellular Physiology|September 10, 2014
Acetylcholine inhibits tumor necrosis factor α activated endoplasmic reticulum apoptotic pathway via EGFR-PI3K signaling in cardiomyocytesYi Miao, Xue-Yuan Bi, Mei Zhao, et al.World Journal of Surgery|January 5, 2020
Prognostic Nomogram for Resected Pancreatic Adenocarcinoma: A TRIPOD-Compliant Retrospective Long-Term Survival AnalysisDong Xu, Kai Zhang, Mingna Li, et al.Journal of Experimental & Clinical Cancer Research : CR|February 15, 2017
PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancerYun-Peng Peng, Yi Zhu, Ling-Di Yin, et al.Molecular Therapy. Oncology|December 1, 2025
Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapyNan Lyu, Olamide T Olaoba, Qiongling Wang, et al.BMC Nephrology|August 11, 2019
Complement activation products in the circulation and urine of primary membranous nephropathyMu-Fan Zhang, Jing Huang, Yi-Miao Zhang, et al.Plos One|June 23, 2020
Complement activation profile of patients with primary focal segmental glomerulosclerosisJing Huang, Zhao Cui, Qiu-Hua Gu, et al.British Journal of Cancer|October 22, 2019
YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathwaysQun Chen, Chuang Yang, Lei Chen, et al.Cell|November 10, 2021
RTN4/NoGo-receptor binding to BAI adhesion-GPCRs regulates neuronal developmentJie Wang, Yi Miao, Rebecca Wicklein, et al.Pageof 56